Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2026-01-11 @ 7:37 AM
Study NCT ID:
NCT04465292
Status:
UNKNOWN
Last Update Posted:
2020-07-10
First Post:
2020-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid
Sponsor:
Brigham and Women's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2020P000025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |